Morgan Stanley Finance LLC has recently filed a pricing supplement for a new structured investment product, known as Contingent Income Memory Auto-Callable Securities, due November 14, 2031. This filing is significant as it reflects the company's ongoing strategy to enhance its investment offerings in the competitive securities market.
The securities are designed to provide investors with a potential opportunity to earn above-market interest rates, albeit with substantial risks. The filing outlines that these securities are unsecured obligations of Morgan Stanley Finance LLC and are fully guaranteed by Morgan Stanley. Investors should be aware that these products do not guarantee the repayment of principal and may result in significant losses.
Background
Morgan Stanley Finance LLC, incorporated in Delaware, operates under the Standard Industrial Classification of Security Brokers, Dealers & Flotation Companies (SIC 6211). The firm is a subsidiary of Morgan Stanley, a prominent player in the financial services industry. The recent filing, dated November 12, 2026, is part of their ongoing efforts to provide innovative financial solutions to investors.
What the Filing Says
The pricing supplement, numbered 19,911, details the terms of the new securities, which are contingent upon the performance of the S&P 500 Futures 40% Intraday 4% Decrement VT Index. The securities will pay a contingent coupon only if the closing level of the underlying index meets certain conditions. If those conditions are not met, investors may receive no interest during the related interest periods.
Additionally, the filing states, “The securities are for investors who seek an opportunity to earn interest at a potentially above-market rate in exchange for the risk of losing a significant portion or all of their principal.” This highlights the inherent risks associated with such structured products.
Impact
This new offering may affect a range of stakeholders, including individual investors seeking higher returns, financial advisors recommending investment products, and competitors in the securities industry. As Morgan Stanley introduces these structured investments, other firms in the same sector may need to adapt their strategies to remain competitive.
What's Next
The filing does not say what happens next, but it is expected that Morgan Stanley will continue to monitor market conditions and investor interest in these products.
For further details, the filing can be accessed through the SEC under accession number 0001839882-26-056229.
Read Next
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement
MiniMed Group receives FDA clearance for new insulin pump
TC Energy unveils expansion plans for NGTL System








